Filtering by:
Prostate CancerStudy Takes the Call for Cancer Screenings to the Pulpit
Cheryl Knott, PhD, an American Cancer Society grantee, takes her research to church. She developed Project HEAL (Health through Early Awareness and Learning) to train a small group of members to be health advisors at a few Black churches in Maryland. They're helping raise awareness about cancer prevention and screening for breast, prostate, and colorectal cancer.
Study: Hormone Treatment for Prostate Cancer Linked With Dementia
Researchers from the University of Pennsylvania found that older prostate cancer patients getting hormone treatment, called androgen deprivation therapy (ADT), were more likely to be diagnosed later with Alzheimer’s disease or dementia.
Prostate Cancer Survivor Reflects on Life After Treatment: ‘I’m still me.’
Brian Glennon says he’s still the same Sinatra-loving, Broadway-going, basketball-coaching 63-year-old man who is grateful for the love of his family. Glennon was diagnosed with prostate cancer after a higher-than-average PSA result prompted him and his doctor to monitor his PSA level more closely.
Facts & Figures 2019: US Cancer Death Rate has Dropped 27% in 25 Years
The death rate from cancer in the US has declined steadily over the past 25 years, according to annual statistics reporting from the American Cancer Society.
New Prostate Cancer Guideline Offers Shortened Radiation Time
Men being treated for early-stage prostate cancer with external beam radiation therapy (EBRT) can safely choose an option that reduces the number of treatment sessions, according to a panel of experts from the American Society for Radiation Oncology, American Society of Clinical Oncology, and American Urological Association.
Annual Report to the Nation: Cancer Death Rates Continue Long Decline
The death rate from cancer in the United States is continuing to fall among men, women, and children, according to the latest Annual Report to the Nation on the Status of Cancer.
FDA Approves Consumer Test for Certain BRCA Mutations
The US Food and Drug Administration (FDA) has approved the first direct-to-consumer tests for certain BRCA1 and BRCA2 gene mutations.
FDA Approves Erleada (Apalutamide) for Some Prostate Cancers
The US Food and Drug Administration (FDA) has approved Erleada (apalutamide) to treat men with non-metastatic castration-resistant prostate cancer.